Search

Your search keyword '"Levey, Allan I"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Levey, Allan I" Remove constraint Author: "Levey, Allan I" Topic aging Remove constraint Topic: aging
29 results on '"Levey, Allan I"'

Search Results

1. Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain.

2. Rationale and Design of the Emory Healthy Aging and Emory Healthy Brain Studies.

3. Differential Phagocytic Properties of CD45 low Microglia and CD45 high Brain Mononuclear Phagocytes-Activation and Age-Related Effects.

4. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.

5. Response to Buslovich and colleagues.

6. Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.

7. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging.

8. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry.

9. Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART

10. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

11. Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease

12. Identification of Conserved Proteomic Networks in Neurodegenerative Dementia

13. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report

14. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

15. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases

16. Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis

17. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept

18. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease

19. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

20. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease

21. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

22. In vivo staging of regional amyloid deposition

23. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load

24. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?

25. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

26. Common genetic variants influence human subcortical brain structures

27. Applying automated MR-based diagnostic methods to the memory clinic: A prospective study

28. Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions.

29. Association of AHA Cardiovascular Health Metrics With Cognitive Function, Depression, and Anxiety: The Emory Healthy Aging Study.

Catalog

Books, media, physical & digital resources